AUPH Overview

Company Profile

Related stocks

ABCL • Canada

AbCellera Biologics Inc.

12.55 USD

4.07B USD 1Y +94.8%

PVLA • United States

Palvella Therapeutics, Inc.

138.77 USD

2B USD 1Y +75.5%

VIR • United States

Vir Biotechnology, Inc.

11.7 USD

1.98B USD 1Y +83.8%

GENB • United States

Generate Biomedicines, Inc.

14.34 USD

1.84B USD

SEPN • United States

Septerna, Inc.

38.37 USD

1.79B USD 1Y +64.1%

URGN • United States

UroGen Pharma Ltd.

36.83 USD

1.8B USD 1Y +113.4%

NUVB • United States

Nuvation Bio Inc.

5 USD

1.76B USD 1Y +33.1%

ATAI • United States

AtaiBeckley Inc.

7.35 USD

2.73B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

64.3% p.a.

Max Drawdown (5Y)

-87.6%

Sharpe Ratio (5Y)

-0.09

Beta Factor

1.61

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 1.61 indicates above-average volatility compared to the broader market.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (64.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -87.6% in the extended horizon.